Dodwell D.J., Abbas S.K., Morton A.R.,
è ñîàâò. Parathyroid hormone related pro
tein (50 69) and response to pamidronate therapy for tumor induced hypercalcaemia //
Eur. J. Cancer. — 1991. — V. 27. — P. 1629 1633.
Dokiya T., Yorozu A.
Palliative radiotherapy for symptomatic osseus metastases //
Nippon Igaku Hoshasen. — 1995. — V. 55(9). — P. 677 681.
Dombernowsky P., Smith I., Falkson G.,
è ñîàâò. Letrozole, a new oral aromatase
inhibitor for advanced breast cancer: double blind randomized trial showing a dose effect
and improved efficacy and tolerability compared with megestrol acetate // J. Clin. Oncol. —
1998. — V.16. — P. 453 461.
Dominguez+Gadea L., Martin+Curto L.M., Crespo A., Avila C.
MCA serum determi
nation in breast carcinoma patients for the diagnosis of bone metastases // Int. J. Biol.
Markers. — 1993. — V. 8(4). — P. 203 207.
Dominkus M., Krepler P., Schwameis E., Kotz R.
Surgical therapy of spinal metastases
// Orthopade. — 1998. — V. 27(5). — P. 282 286.
Donato A.T., Ammerman E.G., Sullesta O.
Bone scanning in the evaluation of the
patients with lung cancer // Ann. Thorac. Surg. — 1979. — V. 27. — P. 300 304.
Douglas P., Rossier P., Mirimanoff R.O., Coucke P.A.
Third body irradiation as an
effective palliative treatment for painful multiple bone metastases resistant to chemo — or
hormonal treatment // Radiother. Oncol. — 1993. — V. 28(1). — P. 76 78.
Drury A.B., Palmer P.H., Higman W.J.
Carcinomatous metastasis to the vertebral
bodies // J. Clin. Pathol. — 1964. — V. 17. — P. 448 457.
Duff G.W.
Peptide regulatory factors in non malignant disease // Lancet I. — 1989. —
P. 1432 1435.
Duffy M.J.
The role proteolytic enzymes in cancer invasion and metastasis // Clin.
Exp. Metastasis. — 1992. — V. 10. — P. 145 155.
Dumon J.C., Wantier H., Mathieu F.
è ñîàâò. Technical and clinical validation of a
new immunoradiometric assay for human osteocalcin // Eur. J. Endocrinol. — 1996. —
V. 135 — P. 231 237.
Duncan G., Duncan W., Maher E.J.
Patterns of palliative radiotherapy in Canada //
Clin. Oncol. (R. Coll. Radiol.). — 1993. — V. 5(2). — P. 92 97.
Duque Gallo J.J., Yarza J.C., Ros L.
El rastreo isotopico en el diagnostico de las
metastases oseas del cancer de mama. Estudio comparaativo con la radiologia y la clinica
// Rev. Esp. Oncol. — 1983. — V. 30(2). — P. 199 207.
Durning P., Best J.J.K., Sellwood R.A.
Recognition of metastatic bone disease in can
cer of the breast by computed tomography // Clin. Oncol. — 1983. — V. 9(4). —
P. 343 346.
Dutreix J.
Concentrated irradiation // Ann. Clin. Res. — 1971. — V. 3. — P. 9 15.
El Domeiri A.A., Shroff S.
Role of preoperative bone scan in carcinoma of the breast
// Surg. Gynecol. Obstet. — 1976. — V. 142. — P. 722 724.
Ellis F.
Fractionation and dose rate in radiotherapy // Basel/New York: Karger. —
1968.
Ellis V., Pyke C., Eriksen J.
è ñîàâò. The urokinase receptor: involvement in cell sur
face proteolysis and cancer invasion // Ann. N.Y. Acad. Sci. — 1992. — V. 667. —
P. 13 31.
England P.C., Sellwood R.A.
Serum prolactin in normal women and women with
benign and malignant breast desease // Cancer Letect and Prov. — 1979. — V 2(3). —
P. 441 451.
224
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
